These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18838593)

  • 21. Cell wall-inhibitory antibiotics activate the alginate biosynthesis operon in Pseudomonas aeruginosa: Roles of sigma (AlgT) and the AlgW and Prc proteases.
    Wood LF; Leech AJ; Ohman DE
    Mol Microbiol; 2006 Oct; 62(2):412-26. PubMed ID: 17020580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolically active subpopulation in Pseudomonas aeruginosa biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms.
    Chiang WC; Pamp SJ; Nilsson M; Givskov M; Tolker-Nielsen T
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):245-56. PubMed ID: 22251216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethanol Stimulates Trehalose Production through a SpoT-DksA-AlgU-Dependent Pathway in Pseudomonas aeruginosa.
    Harty CE; Martins D; Doing G; Mould DL; Clay ME; Occhipinti P; Nguyen D; Hogan DA
    J Bacteriol; 2019 Jun; 201(12):. PubMed ID: 30936375
    [No Abstract]   [Full Text] [Related]  

  • 24. Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa.
    Stickland HG; Davenport PW; Lilley KS; Griffin JL; Welch M
    J Proteome Res; 2010 Jun; 9(6):2957-67. PubMed ID: 20373734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Inducers of the Expression of Multidrug Efflux Pumps That Trigger
    Laborda P; Alcalde-Rico M; Blanco P; Martínez JL; Hernando-Amado S
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of genes in the σ²² regulon of Pseudomonas aeruginosa required for cell envelope homeostasis in either the planktonic or the sessile mode of growth.
    Wood LF; Ohman DE
    mBio; 2012; 3(3):. PubMed ID: 22589289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions.
    Schweizer HP
    Genet Mol Res; 2003 Mar; 2(1):48-62. PubMed ID: 12917802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A deletion mutation in nfxB of in vitro-induced moxifloxacin-resistant Pseudomonas aeruginosa confers multidrug resistance.
    Thai VC; Pham HV; Nguyen DNM; Lambert P; Nguyen TTH
    Acta Microbiol Immunol Hung; 2017 Sep; 64(3):245-253. PubMed ID: 28560883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
    Poole K
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):255-64. PubMed ID: 11321581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudomonas aeruginosa develops Ciprofloxacin resistance from low to high level with distinctive proteome changes.
    Peng J; Cao J; Ng FM; Hill J
    J Proteomics; 2017 Jan; 152():75-87. PubMed ID: 27771372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter regulatory mode evolution enhances the high multidrug resistance of
    Wang C; Yang J; Xu Z; Lv L; Chen S; Hong M; Liu J-H
    mBio; 2024 May; 15(5):e0021824. PubMed ID: 38564664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a "residual" concentration.
    Thomas L; Maillard JY; Lambert RJ; Russell AD
    J Hosp Infect; 2000 Dec; 46(4):297-303. PubMed ID: 11170761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic efflux, a mechanism of multiple resistance in Pseudomonas aeruginosa].
    Pechère JC; Michéa-Hamzhepour M; Köhler T
    Bull Acad Natl Med; 1998; 182(3):599-612; discussion 613-5. PubMed ID: 9673055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates.
    Pasca MR; Dalla Valle C; De Jesus Lopes Ribeiro AL; Buroni S; Papaleo MC; Bazzini S; Udine C; Incandela ML; Daffara S; Fani R; Riccardi G; Marone P
    Microb Drug Resist; 2012 Feb; 18(1):23-32. PubMed ID: 21797666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. nalD encodes a second repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa.
    Morita Y; Cao L; Gould VC; Avison MB; Poole K
    J Bacteriol; 2006 Dec; 188(24):8649-54. PubMed ID: 17028276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane-to-cytosol redistribution of ECF sigma factor AlgU and conversion to mucoidy in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Rowen DW; Deretic V
    Mol Microbiol; 2000 Apr; 36(2):314-27. PubMed ID: 10792719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the mechanism of substrate specificity by resistance nodulation division (RND)-type multidrug resistance pumps: the large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition.
    Mao W; Warren MS; Black DS; Satou T; Murata T; Nishino T; Gotoh N; Lomovskaya O
    Mol Microbiol; 2002 Nov; 46(3):889-901. PubMed ID: 12410844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mvaT mutation modifies the expression of the Pseudomonas aeruginosa multidrug efflux operon mexEF-oprN.
    Westfall LW; Carty NL; Layland N; Kuan P; Colmer-Hamood JA; Hamood AN
    FEMS Microbiol Lett; 2006 Feb; 255(2):247-54. PubMed ID: 16448502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
    Lomovskaya O; Warren MS; Lee A; Galazzo J; Fronko R; Lee M; Blais J; Cho D; Chamberland S; Renau T; Leger R; Hecker S; Watkins W; Hoshino K; Ishida H; Lee VJ
    Antimicrob Agents Chemother; 2001 Jan; 45(1):105-16. PubMed ID: 11120952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the Multidrug Resistance Efflux Pump MexCD-OprJ in the
    Alcalde-Rico M; Olivares-Pacheco J; Alvarez-Ortega C; Cámara M; Martínez JL
    Front Microbiol; 2018; 9():2752. PubMed ID: 30532741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.